The WannaCry cyberattack crippled hundreds of thousands of computers but one organisation appears to have ended up benefiting from the ransomware attack in a big way.
Cambridge cybersecurity startup Darktrace experienced a significant uptick in sales enquiries immediately off the back of the cyberattack that brought the NHS to its knees, according to Emily Orton, one of the company’s founders.
“We got a lot of demand afterwards,” said Orton at the CogX conference in London on Tuesday, adding that customers were particularly interested in Darktrace’s new “Antigena” product that goes out and attacks ransomware and other viruses when it spots it them on the network.
“It was a big driver for us,” Orton said, declining to reveal any exact numbers. “The phones were ringing that day [of the attack] and it was a crazy week for us. From a sales perspective it was a big, big push.”
Founded in Cambridge in 2013, Darktrace has grown to 500 employees and opened offices in London, San Francisco, and Singapore. Its technology is used by over 1,000 customers including the likes of T-Mobile and Telstra, as well as unspecified government agencies.
It has raised $104 million (£82 million) from investors, with Mike Lynch — the billionaire founder of Autonomy, which was sold to HP for $11.7 billion (£9.3 billion)— the company’s lead investor through his venture capital firm Invoke Capital.
The company is getting towards the size where it might start to think about a stock market listing but Orton said: ” I don’t think there will be one for now. I think we need to grow organically.”